| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-09 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.37 | 5e-07 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-06 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-05 |